PREVIOUS
✖
Cervical Cancer vaccine
October 30 , 2022
750 days
871
0
- The production of India's first indigenously developed for the prevention of cervical cancer, will start in the first quarter of 2023.
- This is named as quadrivalent Human Papillomavirus (HPV)- "CERVAVAC" vaccine and developed by the Serum Institute of India.
- This was announced for the prevention of cervical cancer.
- 'CERVAVAC' is an outcome of a partnership of DBT and BIRAC with the Bill and Melinda Gates Foundation, supported by Serum Institute of India Private Limited.
- The indigenous development of quadrivalent vaccine done through its partnership programme 'Grand Challenges India'.
Leave a Reply
Your Comment is awaiting moderation.